Literature DB >> 3384995

Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis.

J T Wilde1, W E Thomas, D A Lane, M Greaves, F E Preston.   

Abstract

Acquired dysfibrinogenaemia as the cause of coagulation abnormalities occurred in a case of acute pancreatitis. Initial coagulation studies showed a prolonged thrombin time and increased concentrations of serum fibrinogen/fibrin degradation products and plasma D-dimer. Further studies on purified fibrinogen showed evidence of degradation of the C-terminal ends of the A-alpha chains, which, it is suggested, resulted from the action of circulating pancreatic proteases. Fibrin polymerisation was thus shown to be impaired, which explains the prolongation of the thrombin time. There was a temporal relation between increased amylase activities and the prolonged thrombin time, both of which returned to normal three weeks after admission. Acquired dysfibrinogenaemia may be an underrecognized phenomenon in acute pancreatitis and may lead to misinterpretation of coagulation test abnormalities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384995      PMCID: PMC1141540          DOI: 10.1136/jcp.41.6.615

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography.

Authors:  C Southan; E Thompson; D A Lane
Journal:  Thromb Res       Date:  1986-07-15       Impact factor: 3.944

2.  High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity.

Authors:  V J Marder; N R Shulman
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

3.  Fibrinogen-fibrin interaction.

Authors:  V A Belitser; T V Varetskaja; G V Malneva
Journal:  Biochim Biophys Acta       Date:  1968-02-19

4.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Study of acquired dysfibrinogenaemia in liver disease.

Authors:  J Soria; C Soria; J J Ryckewaert; M Samama; J M Thomson; L Poller
Journal:  Thromb Res       Date:  1980 Jul 1-15       Impact factor: 3.944

6.  Acquired dysfibrinogenaemia in acute and chronic liver disease.

Authors:  D A Lane; M F Scully; D P Thomas; V V Kakkar; I L Woolf; R Williams
Journal:  Br J Haematol       Date:  1977-02       Impact factor: 6.998

7.  Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.

Authors:  J Martinez; J E Palascak; D Kwasniak
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis.

Authors:  A Lasson; K Ohlsson
Journal:  Thromb Res       Date:  1986-01-15       Impact factor: 3.944

9.  Abnormal fibrin polymerization in liver disease.

Authors:  G Green; J M Thomson; I W Dymock; L Poller
Journal:  Br J Haematol       Date:  1976-11       Impact factor: 6.998

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.